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Compensatory membrane expression of the V-ATPase B2
subunit isoform in renal medullary intercalated cells of
B1-deficient mice
Abstract
Mice deficient in the ATP6V1B1 ("B1") subunit of the vacuolar proton-pumping ATPase (V-ATPase)
maintain body acid-base homeostasis under normal conditions, but not when exposed to an acid load.
Here, compensatory mechanisms involving the alternate ATP6V1B2 ("B2") isoform were examined to
explain the persistence of baseline pH regulation in these animals. By immunocytochemistry, the mean
pixel intensity of apical B2 immunostaining in medullary A intercalated cells (A-ICs) was twofold
greater in B1-/- mice than in B1+/+ animals, and B2 was colocalized with other V-ATPase subunits. No
significant upregulation of B2 mRNA or protein expression was detected in B1-/- mice compared with
wild-type controls. We conclude that increased apical B2 staining is due to relocalization of
B2-containing V-ATPase complexes from the cytosol to the plasma membrane. Recycling of
B2-containing holoenzymes between these domains was confirmed by the intracellular accumulation of
B1-deficient V-ATPases in response to the microtubule-disrupting drug colchicine. V-ATPase
membrane expression is further supported by the presence of "rod-shaped" intramembranous particles
seen by freeze fracture microscopy in apical membranes of normal and B1-deficient A-ICs. Intracellular
pH recovery assays show that significant (28-40% of normal) V-ATPase function is preserved in
medullary ICs from B1-/- mice. We conclude that the activity of apical B2-containing V-ATPase
holoenzymes in A-ICs is sufficient to maintain baseline acid-base homeostasis in B1-deficient mice.
However, our results show no increase in cell surface V-ATPase activity in response to metabolic
acidosis in ICs from these animals, consistent with their inability to appropriately acidify their urine
under these conditions.
 doi:10.1152/ajprenal.00160.2007 
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Compensatory membrane expression of the V-ATPase B2 subunit
isoform in renal medullary intercalated cells of B1-deficient mice.
Am J Physiol Renal Physiol 293: F1915–F1926, 2007. First published
September 26, 2007; doi:10.1152/ajprenal.00160.2007.—Mice defi-
cient in the ATP6V1B1 (“B1”) subunit of the vacuolar proton-
pumping ATPase (V-ATPase) maintain body acid-base homeostasis
under normal conditions, but not when exposed to an acid load. Here,
compensatory mechanisms involving the alternate ATP6V1B2 (“B2”)
isoform were examined to explain the persistence of baseline pH
regulation in these animals. By immunocytochemistry, the mean pixel
intensity of apical B2 immunostaining in medullary A intercalated
cells (A-ICs) was twofold greater in B1/ mice than in B1/
animals, and B2 was colocalized with other V-ATPase subunits. No
significant upregulation of B2 mRNA or protein expression was
detected in B1/ mice compared with wild-type controls. We
conclude that increased apical B2 staining is due to relocalization of
B2-containing V-ATPase complexes from the cytosol to the plasma
membrane. Recycling of B2-containing holoenzymes between these
domains was confirmed by the intracellular accumulation of B1-
deficient V-ATPases in response to the microtubule-disrupting drug
colchicine. V-ATPase membrane expression is further supported by
the presence of “rod-shaped” intramembranous particles seen by
freeze fracture microscopy in apical membranes of normal and B1-
deficient A-ICs. Intracellular pH recovery assays show that significant
(28–40% of normal) V-ATPase function is preserved in medullary
ICs from B1/ mice. We conclude that the activity of apical
B2-containing V-ATPase holoenzymes in A-ICs is sufficient to main-
tain baseline acid-base homeostasis in B1-deficient mice. However,
our results show no increase in cell surface V-ATPase activity in
response to metabolic acidosis in ICs from these animals, consistent
with their inability to appropriately acidify their urine under these
conditions.
proton pump; immunofluorescence; pH homeostasis; urinary acidifi-
cation; Atp6v1b1/ mice
THE MAIN MEDIATOR OF INTRACELLULAR organelle acidification in
eukaryotic cells and of proton (H) secretion along the distal
renal nephron is the ubiquitous vacuolar proton-pumping
ATPase (vacuolar, or V-type, H-ATPase, or V-ATPase). The
V-ATPase is a complex enzyme, consisting of two large
sectors or domains (V0, the transmembrane domain involved in
H translocation, and V1, the cytosolic domain, responsible for
hydrolyzing ATP), which together contain at least 13 distinct
subunits (8, 11, 27, 36, 64). A number of V-ATPase subunits
are known to be encoded by different genes and are expressed in
mammalian tissues as multiple distinct isoforms. Certain subunit
isoforms exhibit a remarkable specificity in terms of tissue and/or
cell type expression, and in some cases even with respect to their
subcellular localization (31, 33, 46, 52, 54, 59, 60).
The V1 cytosolic sector, which constitutes the catalytic
domain of the enzyme, is composed of eight subunits, includ-
ing three copies of the 70-kDa “A” subunit and three copies of
the 56-kDa “B” subunit, both believed to be involved in ATP
binding (28, 68). This latter V-ATPase subunit occurs as two
highly homologous isoforms (sharing 83% identity in their
amino acid sequences in the mouse) encoded, respectively, by
two different genes, ATP6V1B1 (or “B1”, initially referred to
as the “kidney” isoform), encoded by Atp6v1b1, and ATP6V1B2
(or “B2”, originally described as the “brain” isoform), encoded
by Atp6v1b2 (7, 9, 26, 38, 58). Mutations in two of the 22
genes currently known to encode for V-ATPase subunits were
found to cause autosomal recessive forms of distal renal
tubular acidosis (dRTA, or type I RTA), also often associated
with sensorineural hearing loss. These two genes are Atp6v1b1
and Atp6v0a4, which encodes the transmembrane “a” subunit
isoform ATP6V0A4, or “a4” (34, 55, 57). dRTA is a genetic
disease characterized by impaired H secretion by the distal
renal nephron, leading to metabolic acidosis, hypokalemia,
nephrocalcinosis, bone disease, and growth retardation (6).
To investigate the physiological mechanisms of dRTA,
B1/ mice (deficient in the B1 subunit of the V-ATPase)
were engineered as a mouse model for the study of this human
disease (25). Interestingly, unlike human dRTA patients (35),
B1/ mice fed a normal diet were found to develop nor-
mally, without any phenotype of metabolic acidosis, nephro-
calcinosis, or inner ear and hearing abnormalities (24, 25). We
also reported that the apical membrane expression of the B2
isoform was significantly augmented in proton-secreting col-
lecting duct (CD) A-type intercalated cells (A-ICs) of B1/
mice, especially in the inner medulla and in the inner stripe of
the outer medulla (25). Taken together, these data led to the
hypothesis that, under these conditions, B2-containing
V-ATPases could be involved in H transport across the apical
plasma membrane and, thus, compensate for the absence of the
B1 isoform. However, when B1/ mice were challenged
with an acid load (by administering NH4Cl in their drinking
water), they developed a severe systemic acidosis and their
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urine pH was found to be inappropriately alkaline. Functional
data showing no concanamycin-inhibitable, i.e., no V-ATPase-
mediated, H extrusion from cortical collecting duct (CCD)
ICs of B1/ mice also suggested that V-ATPases containing
the B2 subunit isoform may be capable of compensating for the
absence of B1 under some but not all circumstances (25).
Consequently, we set out to investigate these apparently
contradictory findings comprehensively and to elucidate whether
(and, if so, how) apical V-ATPase function in maintaining
body acid-base homeostasis can be preserved in mice devoid of
the V-ATPase B1 subunit isoform. In particular, we aimed to
determine whether the presumed compensatory mechanism
involves the alternate 56-kDa B2 isoform. Given the absence
of V-ATPase-mediated H secretion found in CCD ICs of
B1/ mice, this study was focused on V-ATPase B2 subunit
expression and subcellular distribution, and V-ATPase func-
tion in A-ICs of medullary CDs in mice deficient in the
V-ATPase B1 subunit isoform.
MATERIALS AND METHODS
Antibodies. Three affinity-purified polyclonal antibodies were used.
They were raised against synthetic peptides corresponding to the 10
carboxy-terminal amino acids of ATP6V1A (the V-ATPase 70-kDa A
subunit), ATP6V1B1 (the V-ATPase 56-kDa B1 subunit isoform),
and ATP6V1B2 (the B2 isoform), respectively, as previously de-
scribed (30, 45). The rabbit anti-A and anti-B1 polyclonal antibodies
were characterized previously (13, 30, 46). The affinity-purified
chicken anti-B2 antibody was raised against the same sequence as the
previously described rabbit anti-B2 antibody (45) and was found to
have the same specificity as this antibody (23).
To identify CD A-ICs, we used an anti-AE1 anion exchanger
affinity-purified rabbit polyclonal antibody (2, 10), kindly provided by
Dr. Seth Alper (Harvard Medical School and Beth Israel Deaconess
Medical Center).
The following affinity-purified secondary antibodies were used:
indocarbocyanine (Cy3)-conjugated donkey anti-chicken IgY (HL)
(Jackson ImmunoResearch Laboratories, West Grove, PA) at a final
concentration of 1.5 g/ml and FITC-conjugated goat anti-rabbit IgG
(HL) (Jackson ImmunoResearch Laboratories), at a final concentra-
tion of 25 g/ml.
Tissue preparation. Adult male mice (30–35 g), wild-type (C57BL6,
Jackson Laboratory, Bar Harbor, ME) and B1-deficient (B1/),
were housed under standard conditions and maintained on a standard
diet. Generation and breeding of the original B1/ founders have
been described elsewhere (25). All animals were genotyped by PCR
as described previously (25). Where indicated, mice were challenged
with an acid load by administering 1.5% (280 mM) NH4Cl/1%
sucrose in their drinking water for 24 h. All animal studies were
approved by the Massachusetts General Hospital Subcommittee on
Research Animal Care, in accordance with the National Institutes of
Health, Department of Agriculture, and AAALAC requirements, or by
the local Swiss Veterinary Authority (Veterina¨ramt, Zurich, Switzer-
land), in accordance with Swiss Animal Welfare Laws.
For immunofluorescence experiments, mice were anesthetized us-
ing pentobarbital sodium (50 mg/kg body wt ip, Nembutal, Abbott
Laboratories, Abbott Park, IL) and perfused through the left cardiac
ventricle with PBS (0.9% NaCl in 10 mM phosphate buffer, pH 7.4),
followed by paraformaldehyde-lysine-periodate fixative (PLP; 4%
paraformaldehyde, 75 mM lysine-HCl, 10 mM sodium periodate, and
0.15 M sucrose, in 37.5 mM sodium phosphate), as previously
described (45). Both kidneys were dissected, sliced, and further fixed
by immersion in PLP for 4 h at room temperature and subsequently
overnight at 4°C, then rinsed extensively in PBS, and stored at 4°C in
PBS containing 0.02% sodium azide until use. For immunoblotting
and total RNA extraction, kidneys were harvested from anesthetized
mice, snap frozen in liquid nitrogen, and stored at 80°C until use.
Immunofluorescence and confocal microscopy. PLP-fixed kidney
slices prepared as described above were cryoprotected in PBS con-
taining 0.9 M sucrose overnight at 4°C and then embedded in
Tissue-Tek OCT compound 4583 (Sakura Finetek USA, Torrance,
CA), mounted on a specimen disk, and frozen at 20°C. Sections (4
m) were cut on a Leica CM3050 S cryostat (Leica Microsystems,
Bannockburn, IL), collected onto Superfrost Plus precleaned charged
microscope slides (Fisher Scientific, Pittsburgh, PA), air-dried, and
stored at 4°C until use.
Sections were rehydrated for 3 5 min in PBS and treated with 1%
(wt/vol) SDS for 4 min for retrieval of antigenic sites (19). After being
washed for 3 5 min in PBS and incubated for 10 min in 1% (wt/vol)
BSA in PBS with 0.02% sodium azide to reduce nonspecific staining,
the sections were incubated for 90 min with the primary antibody
diluted in Dako antibody diluent (Dako, Carpinteria, CA) at room
temperature, as described previously (45). After 3  5-min PBS
washes, the secondary antibody was applied for 1 h at room temper-
ature and the slides were then rinsed again in PBS for 3  5 min. For
dual immunostaining, the above protocol was first carried out using
the anti-B2 antibody and the corresponding anti-chicken secondary
antibody, and then repeated for the second primary antibody as
appropriate, followed by the respective anti-rabbit secondary anti-
body. Slides were mounted in Vectashield medium (Vector Labora-
tories, Burlingame, CA) for microscopy and image acquisition.
Digital images were acquired as described previously (45) by
using a Nikon Eclipse 800 epifluorescence microscope (Nikon
Instruments, Melville, NY) equipped with an Orca 100 CCD
camera (Hamamatsu, Bridgewater, NJ). Confocal laser-scanning
microscopy imaging was performed on a Radiance 2000 confocal
microscopy system (Carl Zeiss MicroImaging, Thornwood, NY)
using LaserSharp 2000 version 4.1 software. Epifluorescence and
confocal images were analyzed using IPLab version 3.2.4 image-
processing software (Scanalytics, Fairfax, VA) and then imported
into and printed from Adobe Photoshop version 6.0 image-editing
software (Adobe Systems, San Jose, CA).
Quantification of mean pixel intensity of apical B2 immunostaining.
Sections from four B1/ and four B1/ mice were immuno-
stained concurrently and under identical conditions, and all digital
images were acquired using the same exposure parameters, including
no processing, same exposure time (38 ms), and same image size. This
exposure time was selected to ensure maximal intensity while pre-
venting signal saturation. Basolateral staining for the AE1 anion
exchanger was used to identify CD A-ICs. Cells for which the
nucleus, the apical membrane, and/or the lumen of the tubule were not
clearly visible due to the section cut were excluded from the analysis.
The segmentation function in the IPLab software was used to select
the areas corresponding to the B2-associated fluorescence in the apical
region of the A-ICs. The mean pixel intensity (MPI) of every such
area was measured, and these data were imported into Microsoft Excel
version 10 (Microsoft, Redmond, WA) for further statistical analysis.
The final calculation included an average of 83 inner medullary
collecting duct (IMCD) A-ICs per wild-type mouse and 99 IMCD
A-ICs per B1-deficient mouse, with no fewer than 50 cells being taken
into account for any given animal. Summary data are expressed for
each group as means  SD.
Immunogold electron microscopy. Small pieces of PLP-fixed
mouse kidney (1 mm3) from the inner stripe (IS) of the outer
medulla (OM) were cryoprotected in PBS containing 2.3 M sucrose.
Ultrathin cryosections were cut on a Leica EM FCS (Leica Micro-
systems) at 80°C and collected onto formvar-coated gold grids.
Sections were incubated on drops of anti-B2 antibody diluted in Dako
antibody diluent for 2 h at room temperature. After being rinsed in
PBS, the grids were incubated on drops of goat anti-chicken IgG
secondary antibody coupled to 10 nm gold particles (Ted Pella,
Redding, CA) for 1 h at room temperature. The grids were subse-
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quently rinsed in distilled water, stained on drops of a uranyl acetate/
tylose mixture for 10 min on ice, and then collected on loops and
allowed to dry, as previously described (45). Sections were examined
in a JEM-1011 transmission electron microscope (JEOL, Tokyo,
Japan) at 80 kV, and images acquired using an AMT digital imaging
system (Advanced Microscopy Techniques, Danvers, MA) were sub-
sequently imported into and printed from Adobe Photoshop.
Freeze-fracture electron microscopy. Wild-type and B1-deficient
mice were anesthetized as described above and perfused through the
left ventricle with PBS, followed by 2.5% glutaraldehyde in 0.1 M
sodium cacodylate buffer. Kidneys were removed, and the IS of the
OM was rapidly dissected and cut into smaller pieces in the fixative.
After a further 4-h fixation at room temperature, tissues were rinsed in
0.1 M sodium cacodylate buffer and stored at 4°C until further use.
After cryoprotection for at least 1 h in 30% glycerol, tissue pieces
were placed on a copper freeze-fracture support and frozen in freon 22
cooled by liquid nitrogen. Freeze-fracture replicas from tissues or
cells were produced as previously described (51, 62, 63). After
removal from the freeze-fracture device, the replicas were cleaned by
immersion for 2 h in concentrated sodium hypochlorite bleach. Rep-
licas were washed for 3  5 min with distilled water, collected on
copper EM grids, and examined with a JEM-1011 electron micro-
scope. Areas of plasma membranes from 10 A-ICs from B1/ and
B1/ mice were photographed at a final magnification of
100,000. The number of rod-shaped intramembranous particles
(IMPs) was counted on digital images and is expressed as the number
per square micron of membrane surface area.
Protein extraction and immunoblotting. Mouse kidney tissues were
cut into smaller pieces and disrupted with a Tenbroeck tissue grinder
in 3 ml of homogenization buffer (10 mM TrisHCl pH 7.4, 160 mM
NaCl, 1 mM EGTA, 1 mM EDTA, and Complete protease inhibitors
from Roche Applied Science, Indianapolis, IN, containing Triton
X-100 at a final concentration of 1% and 0.05% Igepal CA-630).
Homogenates were centrifuged for 15 min at 16,200 g, 4°C, and the
supernatant was collected, aliquoted, and stored at 80°C. The
protein concentration was determined with the bicinchoninic acid
protein assay (Pierce Biotechnology, Rockford, IL) using albumin as
a standard. Sixty micrograms of protein were diluted in Laemmli
reducing sample buffer, boiled for 5 min, and loaded onto Tris-glycine
polyacrylamide 4–20% gradient gels (Cambrex Bio Science, Rock-
land, ME). After SDS-PAGE separation, proteins were transferred
onto an Immun-Blot polyvinylidene difluoride membrane (Bio-Rad
Laboratories, Hercules, CA), and the membrane was blocked and
incubated overnight at 4°C with the primary antibody diluted 1:2,000
in Tris-buffered saline containing 2.5% milk. The membrane was
subsequently washed and incubated with a secondary antibody con-
jugated to horseradish peroxidase for 1 h at room temperature as
previously described (45). Following four additional washes, antibody
binding was detected with the Western Lightning chemiluminescence
reagent (PerkinElmer Life Sciences, Boston, MA). For quantitative
analysis of protein bands from immunoblotting experiments, digital
images of the membranes were acquired using the EpiChemi3 imaging
system (UVP, Upland, CA) and analyzed using LabWorks 4.6 soft-
ware (UVP).
Total RNA extraction, reverse transcription, and PCR. Total RNA
was isolated from kidneys using the RNeasy Midi kit (Qiagen,
Valencia, CA) per the manufacturer’s specifications. The RNA puri-
fication included an on-column removal of genomic DNA contami-
nation using the RNase-free DNase set (Qiagen). The amount of
extracted RNA was quantified by spectrometry. Extracted RNA was
reverse transcribed (RT) and conventional and quantitative real-time
PCR (qRT-PCR) were performed with RT products as templates for
up to 40 cycles as previously described (23, 32). qRT-PCR was
performed using the SYBR Green PCR Master Mix (Applied Biosys-
tems, Foster City, CA) and the 7300 Real Time PCR System (Applied
Biosystems). The oligonucleotide primers designed to amplify short
sequences of the mouse Atp6v1b2 and Gapd (encoding for GAPDH)
were as follows: cgaactgtttatgagactttggacatt (Atp6v1b2 forward
primer), ggtgctctgagggattctcttc (Atp6v1b2 reverse primer), tgagcaa-
gagaggccctatcc (Gapd forward primer), and ccctaggcccctcctgttat (Gapd
reverse primer) (Sigma-Genosys, The Woodlands, TX). Each qRT-
PCR reaction was performed in triplicate. Products were also analyzed
by electrophoresis on a 2% agarose gel containing GelStar stain
(Cambrex Bio Science). The amplicon sizes are 87 (Atp6v1b2) and 98
bp (Gapd).
Intracellular pH measurements. Outer medullary collecting ducts
(OMCDs) and the initial part of IMCDs were isolated from control or
acid-loaded mouse kidneys and transferred onto glass coverslips as
described previously (65, 66).
Coverslips were transferred to a thermostatically controlled perfu-
sion chamber (at a flow rate of 3 ml/min) maintained at 37°C on a
Zeiss Axiovert 200 inverted microscope equipped with a video im-
aging system (Visitron, Munich, Germany). The isolated tubules were
incubated in a HEPES-buffered Ringer solution containing the pH-
sensitive dye BCECF-AM (10 M, Invitrogen-Molecular Probes,
Eugene, OR) for 20 min and were washed to remove all non dees-
terified dye. Intracellular pH (pHi) was monitored by alternately
exciting the dye with a 10-m-diameter spot of light at 495 and 440
nm while monitoring the emission at 532 nm with a video imaging
system. Each experiment was calibrated for pHi using the nigericin/
high-K method, and the obtained ratios were converted to pHi as
described previously (61, 65, 66). All experiments were performed in
the nominal absence of bicarbonate. The initial solution was a
HEPES-buffered Ringer solution (in mM: 125 NaCl, 3 KCl, 1 CaCl2,
1.2 MgSO4, 2 KH2PO4, 32.2 HEPES, pH 7.4). Cells were acidified
using the NH4Cl (20 mM) prepulse technique and washed with a
Na-free solution (Na was replaced by equimolar concentrations of
N-methyl-D-glucamine). The rate of V-ATPase activity was deter-
mined as the concanamycin-sensitive pHi alkalinization rate in the
absence of Na. Rates were calculated over the same range of pHi
(6.55–6.75) for all cells studied. All chemicals used for pHi measure-
ments were from Sigma-Aldrich (St. Louis, MO) and Calbiochem
(Darmstadt, Germany).
RESULTS
Subcellular localization of B2 V-ATPase in renal CD ICs.
The novel anti-ATP6V1B2 (V-ATPase B2 subunit isoform)
antibody raised in chicken allowed us to perform for the first
time a dual immunostaining experiment for both 56-kDa B
isoforms in the mouse kidney. As previously published for
mouse and other species by us (39, 45) and others (26, 41, 47),
ATP6V1B1 (B1) is expressed in the renal CD at high levels in
all ICs. B1 localizes to the apical plasma membrane and
subapical domain in A-ICs, and in some cases also assumes, at
lower levels, a more diffuse staining pattern. In B-ICs, B1
expression is often localized to the basolateral plasma mem-
brane and, at lower levels, throughout the cytosol, and some-
times even to the apical/subapical domain in a bipolar staining
pattern (Fig. 1), as previously described (15, 17). On the other
hand, the B2 isoform tends to assume a less polarized local-
ization, especially in the CCDs, although even here, but in
particular in the medullary CD A-ICs, the B2 levels appear to
be more elevated in the region between the apical membrane
and the nucleus, as previously shown (45). Accordingly, this
region is characterized by the highest degree of coexpression of
the two isoforms, while the basolateral plasma membrane
stains predominantly for B1 (in B-ICs). The cytosol appears to
contain significantly more B2 than B1, which is to be expected
given the well-known B2 presence on the membranes of
intracellular organelles (18, 45, 64).
F1917B2 V-ATPase MEMBRANE EXPRESSION IN B1/ MOUSE KIDNEY
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In the B1-deficient mouse kidney, and particularly in the
OMCD and IMCD A-ICs of B1/ mice, B2 localization is
considerably more polarized (Fig. 2). A-ICs were clearly iden-
tified here by double staining with an anti-AE1 antibody,
which stains basolateral membranes of this cell subtype, but
not B-ICs, nor principal cells of the CD. As previously shown
for IMCD A-ICs (25), in numerous OMCD A-ICs B2 also
localizes significantly more to the apical plasma membrane,
where it exhibits a thin line of bright staining.
Immunogold electron microscopy was used to support the
immunohistochemical data presented above by confirming that
the V-ATPase B2 subunit isoform localizes to the apical
plasma membrane of B1/ mouse CD A-ICs. In the repre-
sentative example shown here of a CD A-IC from the IS of the
OM (Fig. 3), immunoelectron microscopy demonstrates that
the B2 subunit isoform can be located on the apical membrane,
besides being expressed in the subapical region.
To ensure that the B2 isoform localized to the A-IC apical
membrane in B1/ mice is incorporated into functional
V-ATPase holoenzymes, we performed dual immunostaining
experiments with other V-ATPase subunits, such as ATP6V1A
(the 70-kDa A subunit) and ATP6V1E1, the ubiquitous 31-kDa
“E1” subunit isoform, formerly known as ATP6E2 (31). Both
subunits are part of the cytosolic V1 domain of the enzyme and
were chosen because A is the V-ATPase subunit involved in
the closest interaction with B (as they form an A3B3 hexamer,
a subdomain of V1), while E1 is thought to play an essential
role in the V0-V1 assembly (3) and moreover was previously
shown to relocate from the cytosolic to the apical membrane
domain in response to either chronic acidosis (5) or chronic
carbonic anhydrase inhibition by acetazolamide (4, 45). We
found B2 V-ATPase to colocalize in a tight apical band in
B1/ mouse medullary CD A-ICs with both A (Fig. 4) and
E1 subunits (not shown; see Ref. 25 for the IM).
Quantitative B2 V-ATPase immunofluorescence in IMCD of
wild-type and B1/ mice. The B2 immunofluorescence re-
sults in wild-type and B1-deficient mouse medullary CDs
presented above (Fig. 2) suggest that, in the absence of the
56-kDa B1 isoform, the alternate B2 subunit isoform relocates
to a large extent from a subapical and cytosolic location to the
apical membrane domain. To test this hypothesis, we per-
formed measurements of the MPI of the B2-associated immu-
nostaining in IMCD A-ICs of B1/ and B1/ mice.
To perform the MPI quantification, IMCD A-ICs were
positively identified in both groups of animals by double
staining with an anti-AE1 antibody (Fig. 5, A and B). Grayscale
images of the B2 immunostaining taken with the same set of
exposure parameters (Fig. 5, C and D) were used for the
quantification, and the areas corresponding to B2 immunoflu-
orescence in the apical region of these cells were selected using
Fig. 1. Dual immunofluorescence staining for the V-ATPase B1 (green) and B2 (red) subunit isoforms in wild-type mouse kidney cortex (CO; A–C), inner stripe
(IS) of the outer medulla (D–F), and inner medulla (IM; G–I). The B1 subunit is present in all collecting duct intercalated cells (ICs) in the cortex (A), IS (D),
and IM (F), and also in distal convoluted tubules (DCT; A). B2 is coexpressed with B1 in these cells (B), but B2 is the only 56-kDa subunit isoform detected
in proximal tubules (PT), as additionally shown in the merged image (C). B2 is also expressed at lower levels in principal cells of the collecting duct in the cortex,
IS (E), and IM (H) in the absence of any detectable B1 expression. In the ICs of the medullary collecting duct, B2 is localized in the apical/subapical membrane
domain and also diffusely throughout the cytosol, as illustrated by the higher magnification images of IS (E and F) and IM collecting ducts (H and I). Bars 
10 m.
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the segmentation function in the IPLab software (Fig. 5, E–H).
The immunostained areas are relatively large in wild-type
animals, frequently covering a substantial part of the region
between the apical membrane and the cell nucleus (Fig. 5E),
while the apical staining in B1/ mice is brighter, although
restricted to a very narrow band (Fig. 5G).
Apical MPI values were determined for an average of 83
cells per B1/ mouse and 99 cells per B1/ mouse. These
MPI values were averaged for each of the four animals in every
group, and the mean MPI per group was 925  88 for B1/
mice and 1,860  127 for B1/ mice (Fig. 6). Statistical
ANOVA and t-test analyses were performed and demonstrated
that the differences between the two groups of animals were
statistically significant. When the MPI value set from any of
the four B1-deficient animals is compared with the MPI values
from any of the four wild-type mice, the difference was highly
significant (P  0.001).
As indicated above (Figs. 2 and 5), in the A-ICs of B1/
mice B2 immunostaining within the cytosolic phase appears to
decrease, while the apical plasma membrane staining intensi-
fies significantly. This is confirmed quantitatively not only by
the twofold increase seen in MPI but also by a decrease in the
mean surface area of the region exhibiting the highest levels of
B2 immunostaining. Surface area of the regions used in the
above MPI calculations was also measured for every cell using
the IPLab segmentation function and was found to decrease, on
average, from 344  58 squared pixels (px2) in B1/ mice
to 133  62 px2 in B1/ mice (n  4 for each group) (P 
0.0025).
Freeze-fracture analysis of A-IC membranes. It has been
demonstrated previously that plasma membranes and intracel-
lular vesicles from proton-secreting cells, including renal ICs,
contain a highly characteristic class of IMPs known as “rod-
shaped particles” (RSPs) (15, 29, 43, 56). Based on their
appearance in membranes with high V-ATPase content, they
are believed to represent transmembrane domains of the V-
ATPase (16). When OMCD A-ICs from B1/ mice were
examined by this technique, abundant rod-shaped IMPs were
found associated with their apical plasma membrane domains,
as expected. As shown in Fig. 7, similar IMPs were also found
in B1/ mice, but their density appeared to be reduced.
Quantification of freeze-fracture replicas indeed showed a
decrease in the rod-shaped IMP content of A-IC membranes
from B1-deficient mice compared with normal mice, from
3,737  933 RSPs/m2 (mean  SD, n  5 regions from 3
A-ICs) in B1/ mice to 1,950  514 RSPs/m2 in B1/
mice (n  7 regions from 4 A-ICs). This decrease was found
to be statistically significant by t-test analysis (P  0.0016).
Fig. 2. Immunocytochemical localization of
the B2 V-ATPase (red) in the A-type ICs
(A-ICs) of the collecting duct in wild-type
and B1-deficient (B1/) mice. A-ICs were
identified by double staining with an anti-
AE1 antibody (green). When B1/ mice
are compared with their wild-type counter-
parts, the B2 immunostaining pattern is seen
to shift from a diffuse cytoplasmic staining
to a polarized localization that appears as a
thin, bright band of apical membrane stain-
ing in the outer stripe (OS; A and B) and IS
of the outer medulla (C and D) and in the IM
(E and F). Bars  10 m.
Fig. 3. Immunogold electron microscopy of an inner medullary collecting duct
A-IC from B1-deficient mouse kidney using an anti-B2 V-ATPase antibody.
Numerous gold particles are seen localized to the apical plasma membrane
domain and to the microvilli (arrows), confirming B2 membrane expression as
suggested by the immunofluorescence experiments. Bar  0.2 m.
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V-ATPase B2 subunit redistributes to the cytosolic phase in
colchicine-treated B1/ mice. V-ATPases have been shown
to recycle rapidly between cytoplasmic vesicles and the cell
membrane in proton-secreting epithelial cells (12, 14, 44, 49,
50). Colchicine, an inhibitor of microtubule polymerization,
was previously found to disrupt this recycling (20, 21). CD ICs
of both subtypes were shown to respond to colchicine treat-
ment by shifting from a polarized V-ATPase distribution to a
dispersed cytosolic staining pattern (20). We consequently
examined the effect of colchicine treatment on B2-containing
Fig. 4. Double immunofluorescence localization of B2 (red) and A (green) subunits of the V-ATPase in the IS of the outer medulla (A and C) and IM (D–F)
of B1/ mouse kidney. In both regions, these 2 subunits are coexpressed at the level of the apical plasma membrane, seen clearly as yellow staining in the
merged images (C and F). Bars  10 m.
Fig. 5. Quantification of mean pixel intensity of B2 V-ATPase-associated immunofluorescence. IM collecting duct A-ICs from wild-type (A) and
B1-deficient mice (B) were identified by staining with an anti-AE1 antibody (green), and B2 immunostaining (red) was quantified from the respective
grayscale pictures [B1/ (C) and B1/ (D)] acquired with identical exposure parameters. For a typical wild-type A-IC (E) designated in A (arrow),
the immunostained area was selected (F) using the segmentation function of IPLab software, and the associated MPI was measured. B1-deficient A-ICs
were treated identically; shown here is a cell (G) chosen from B (arrow), which exhibits a much narrower yet brighter immunostained region in the apical
membrane domain (H). Bars  15 m.
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V-ATPases in B1/ mice. Medullary CD A-ICs from B1-
deficient mice injected with colchicine (0.5 mg/100 g body wt
ip) 4 h before perfusion fixation showed no significant differ-
ence in B2 distribution compared with untreated B1/ mice
(data not shown). However, when the duration of colchicine
treatment was increased to 17 h, the B2 V-ATPase staining
pattern in most IMCD and ISCD A-ICs shifted drastically from
the polarized staining described above (Figs. 2, 4, and 5) to a
diffuse pattern, with B2 being localized throughout the cyto-
plasm (Fig. 8). Some cells continued to display detectable
apical membrane staining after colchicine treatment, but even
these cells also showed significant subapical and/or cytosolic
B2 immunofluorescence. This result is similar to that obtained
previously in colchicine-treated kidneys from normal rats (20),
thus allowing for a similar conclusion, i.e., that apical targeting
of B2-containing V-ATPases in B1/ mice is affected by
microtubule disruption and that the B2 subunit recycles be-
tween the plasma membrane and an intracellular vesicular
pool.
V-ATPase B2 subunit isoform mRNA and protein expression
in wild-type and B1/ mice. The apical plasma membrane
B2 immunostaining increases significantly in B1/ mice, as
indicated by the doubling of the immunofluorescence MPI
compared with the wild-type mouse group (Fig. 6). We further
investigated whether this increase is due only to a relocaliza-
tion of B2-containing V-ATPases from the cytosolic compart-
ment to the cell membrane, or additionally to an increase in the
levels of B2 mRNA and protein.
Conventional and qRT-PCR analysis performed with RNA
isolated from whole kidneys yielded similar Atp6v1b2 mRNA
signals in all samples, whether extracted from B1/ or
B1/mouse kidneys (Fig. 9A). Results for Atp6v1b2 mRNA
from three different qRT-PCR experiments performed in three
animals from each group show no statistically significant
upregulation in B2 mRNA expression induced by the lack of
the B1 isoform (Fig. 9B).
However, since these findings do not preclude the possibility
of a compensatory increase in B2 at the protein level in B1/
mice, we also performed immunoblotting experiments for B2
in wild-type and B1-deficient mice. We showed previously that
immunoblotting of total kidney homogenates revealed, as ex-
pected, intense B1 expression in B1/ and B1/ mice, but
no signal in B1/ mice (25). We now report that there is no
detectable upregulation of B2 expression in B1/ mice
compared with their B1/ (Fig. 10A) and B1/ counter-
parts (data not shown). The intensity of the chemiluminescence
corresponding to the B2 and actin protein bands from this
immunoblotting experiment was quantified, and B2 results
were normalized to their respective actin loading controls and
subsequently to the mean value of the B1/ group. Normal-
Fig. 6. Mean pixel intensity (MPI) of apical B2 V-ATPase-associated immu-
nofluorescence in 4 wild-type (/, black bars) and 4 B1/ (gray bars)
mice is shown here as means  SD. The dark gray bar represents the average
of the B1/ group, 925 88 (n 4). The average MPI of all cells quantified
from the 4 wild-type animals was 924. The open bar represents the average of
the B1/ group, 1,860  127 (n  4), representing an approximately 2-fold
increase over the wild-type group. The corresponding average MPI of all
A-ICs quantified from B1-deficient mice was 1,868.
Fig. 7. High-resolution freeze-fracture anal-
ysis of outer medullary collecting duct
(OMCD) A-ICs from B1/ and B1/
mouse kidney. OMCD A-ICs from B1/
mice exhibit abundant rod-shaped intramem-
branous particles associated with their apical
membranes (A), while B1/ mouse OMCD
A-ICs contain similar but fewer such parti-
cles (B). To emphasize the difference in
rod-shaped particle density, regions indi-
cated by arrows in A and B are shown at a
higher magnification in C (wild-type mouse)
and D (B1-deficient mouse). Bars 100 nm.
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ized results show no statistically significant difference be-
tween the B1-deficient and the wild-type animals (n  3 for
each group, Fig. 10B). Quantitative immunoblotting was
performed three different times, and every experiment
yielded similar results. We can thus conclude that the lack of
the B1 subunit isoform does not induce an increase in the B2
expression in the kidney at the total mRNA or total protein
level, in agreement with results published recently for the
epididymis (23). Consequently, the elevation in apical mem-
brane B2 immunostaining may not be due to an increase in
the amount of B2 protein.
Fig. 8. Confocal microscopy showing double immunostaining for AE1 (green, A and D) and B2 V-ATPase (red, B and E) of ICs from colchicine-treated
B1-deficient mouse IS of the outer medulla (A–C) and IM (D–F). Compared with the B2 staining seen ordinarily in medullary A-ICs of untreated B1/ animals
(see Figs. 2, 4, and 5), these animals show, in response to colchicine treatment, significantly less membrane-associated B2 staining and more cytosolic diffuse
staining. Bars  15 m.
Fig. 9. Expression of Atp6v1b2 mRNA in the kidney of wild-type and
B1-deficient mice. Total RNA was isolated from B1/ and B1/ mouse
kidney and genomic DNA contamination was removed. Conventional and
quantitative real-time (qRT)-PCR analysis was performed and products were
resolved on a 2% agarose gel. Results show similar Atp6v1b2 mRNA signals
in B1/ and B1/ mouse kidneys (A). qRT-PCR analysis for Gapd was
performed as a control. Atp6v1b2 mRNA data from 3 different experiments
performed on n  3 animals from each group were normalized to their
respective Gapd mRNA values and subsequently to the average of the B1/
group. Results are shown here as means  SE (B). No statistically significant
difference was found at the B2 mRNA level between B1-deficient (gray bar)
and wild-type mice (black bar).
Fig. 10. Detection of the V-ATPase B2 subunit in total kidney homogenate by
immunoblotting. Sixty micrograms of B1/ and B1/ mouse kidney
homogenate were subjected to SDS-PAGE and blotted with a chicken anti-B2
antibody (A). A specific 56-kDa band of similar intensity is seen in B1/ and
B1/ animals. Loading control was performed with an anti-actin antibody.
The chemiluminescence intensity of the B2 and actin protein bands from A was
quantified, and the normalized results (B) show no statistically significant
difference between B1/ (gray bar) and B1/mice (black bar). Values are
means  SE; n  3 for each group.
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V-ATPase activity in medullary CD A-ICs of B1/ mice.
To assess V-ATPase function in wild-type and B1-deficient
mice, we measured the rate of recovery of pHi after acute
cellular acidification in A-ICs from IMCDs and OMCDs in
both animal groups. For every animal studied, measurements
were performed in the presence and absence of concanamycin
(100 nM), and the rate of V-ATPase activity was determined as
the concanamycin-sensitive pHi alkalinization rate. On aver-
age, 140 cells were investigated for each experimental condi-
tion (B1/ vs. B1/ mice, OMCD vs. IMCD, untreated
control vs. concanamycin-treated).
Summary data show that in OMCD A-ICs of B1/ mice
the baseline pHi recovery rate was 0.047 0.002 pH units/min
(mean  SE, n  98 cells) and was reduced by concanamycin
to 0.024  0.001 pH units/min (n  144 A-ICs), correspond-
ing to a fraction of 50% of the proton efflux, i.e., a rate of
0.023  0.002 pH units/min, being V-ATPase-dependent
(Fig. 11). In comparison, measurements in B1/ mouse
A-ICs (control: n  119 cells and concanamycin-treated: n 
225 cells) yielded a V-ATPase-mediated pHi alkalinization rate
of 0.009  0.001 pH units/min, with a baseline pHi recovery
rate of 0.028  0.002 pH units/min, decreasing to 0.019 
0.001 pH units/min in the presence of concanamycin. We
conclude that a significant fraction (40%) of the V-ATPase
activity in the OMCD A-ICs is preserved despite the absence
of the B1 subunit.
Analyzing the measurements for IMCD A-ICs in a similar
way reveals that the V-ATPase-mediated pHi recovery rate was
0.019  0.003 pH units/min in the wild-type animals (control:
n  153; concanamycin: n  132 cells), slightly (but not
significantly) lower than in the OMCD. This was reduced
further in B1-deficient mice to 0.005  0.002 pH units/min
(control: n  153; concanamycin: n  100 cells). Therefore,
V-ATPase function in the apical membrane of IMCD A-ICs in
animals lacking the B1 subunit isoform is decreased to 28%
of the level found in wild-type mice. Importantly, the pHi
recovery rate in the presence of concanamycin was similar in
the two animal groups: 0.035  0.002 pH units/min (wild-
type) and 0.033  0.002 pH units/min (B1-deficient mice).
Analyses of the four data sets demonstrated that in all cases
studied, the concanamycin treatment induced a statistically
significant reduction in the H-extrusion rate from A-ICs (P
0.05 for B1/ IMCD, P  0.0001 for B1/ OMCD, and
P  0.0001 for B1/, both IMCD and OMCD), thus con-
firming the presence of plasma membrane, concanamycin-
sensitive V-ATPase activity in OMCD and IMCD A-ICs from
both wild-type and B1-deficient mice.
We also determined the rate of recovery of pHi in A-ICs
from OMCDs of acid-loaded B1/ vs. B1/ mice. The
oral administration of NH4Cl (280 mM for 24 h) was previ-
ously shown to cause a significant reduction in systemic pH in
both wild-type and B1-deficient mice (25). In acid-loaded
wild-type mice, concanamycin-sensitive V-ATPase activity
was 0.029  0.002 pH units/min (control: n  40; concana-
mycin: n  44 cells), representing a 26% increase over the
rate found in unchallenged animals. In contrast, B1-deficient
mice showed no stimulation of the V-ATPase activity fol-
lowing the acid loading; the V-ATPase-mediated pHi alka-
linization rate was 0.005  0.002 pH units/min in this group
(control: n  39; concanamycin: n  36 cells). Similar to the
case of unchallenged animals, there were no statistically sig-
nificant differences in the pHi recovery rate in the presence of
concanamycin following the acid challenge in the two animal
groups. Immunofluorescence localization of B2 V-ATPase in
acid-loaded B1/ mice (data not shown) was indistinguish-
able from the pattern seen in unchallenged animals, in which a
tight apical localization of the B2 subunit was already detect-
able (Figs. 2, 4, and 5).
DISCUSSION
Mice lacking the V-ATPase 56-kDa ATP6V1B1 (B1) sub-
unit isoform are able to partially compensate for its loss via a
mechanism that is sufficient to maintain acid-base balance in
various organ systems under baseline conditions (25). In this
study, we investigated the role of the alternate 56-kDa
ATP6V1B2 (B2) isoform in this compensatory mechanism. B2
generally assumes a diffuse intracellular localization, although
in some cells, especially in medullary CD A-ICs, it is more
concentrated in the apical region, as shown previously (45).
This staining pattern is consistent with the B2 isoform being
present on intracellular organelles such as endosomes, lyso-
somes, and parts of the Golgi/trans-Golgi network, where it
plays a “housekeeping” role in acidification processes that are
important to a variety of cellular functions (27, 40, 42, 47, 64).
However, the B2 isoform is not entirely intracellular and can
be detected on the plasma membrane of various cells, including
certain renal epithelial cells, indicating that it contributes to H
secretion under some conditions and in some tissues. For
example, proximal tubule epithelial cells normally express
apical membrane-associated V-ATPases containing the B2
isoform (18, 45, 64) and, in osteoclasts, membrane expression
of V-ATPases containing the B2 and not the B1 isoform
mediates H transport across the ruffled membrane to permit
bone resorption (37). We previously described abundant apical
B2 expression in A-ICs from CDs of rats treated with
acetazolamide, a condition in which H secretion by ICs
appears to be stimulated to compensate for decreased proximal
bicarbonate reabsorption that would otherwise lead to severe
metabolic acidosis (45).
More recently, we reported that A-ICs from the B1/
mouse kidney showed a more apically polarized distribution of
Fig. 11. V-ATPase activity measured as concanamycin-inhibitable intracellu-
lar pH (pHi) recovery rate in A-ICs from the outer medulla (OM) and IM of
B1/ and B1/ mice is shown here as means  SE. V-ATPase-mediated
pHi recovery rate is maintained in the OM of B1-deficient mice at a level
corresponding to 40% of the V-ATPase activity in wild-type mice. In IMCD
A-ICs of B1/ mice, V-ATPase function represents 28% of the value
found in wild-type mice.
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the B2 subunit (25), and we now demonstrate that a significant
portion (28–40%) of wild-type plasma membrane V-ATPase
activity is retained in medullary A-ICs from B1-deficient mice.
We propose that this level of V-ATPase activity is sufficient to
maintain normal acid-base levels in B1/ mice, but that the
reduced proton secretory capacity of A-ICs is limiting upon
acid loading of the animals, which then develop severe meta-
bolic acidosis with acidemia (25). The lack of stimulation of
V-ATPase activity in outer medullary CD A-ICs of B1/
mice in response to acid loading reported here provides at least
a partial explanation for these findings. Furthermore, it has
recently been shown that angiotensin II fails to increase pHi
recovery in ICs from B1-deficient mice (48). These data,
combined with our present findings, could indicate 1) that B2
incorporation/activity in the plasma membrane of B1-deficient
mice is already at maximum levels and cannot be increased in
response to further challenges, and/or 2) that increased plasma
membrane incorporation of B2-containing holoenzymes in
response to physiological stimuli is impaired due to the ab-
sence of some as yet unknown trafficking or targeting sequence
that might be present in the B1 isoform. Nevertheless, while it
is clear that under normal circumstances most of the H
secretory activity of ICs is mediated by V-ATPases containing
the B1 subunit, it is also now apparent that this activity can be
supplemented in extreme conditions (such as the acetazolamide
treatment of animals) (4, 45) or partially replaced (in B1/
mice) by V-ATPase holoenzymes that contain B2, as shown in
the present study.
V-ATPase insertion into the apical plasma membrane of
A-ICs from B1-deficient mice is also suggested by the presence
of RSPs on these membranes. RSPs have long been associated
with the V-ATPase in a variety of cell types (15, 16, 29, 43,
56), although whether they actually represent V-ATPase trans-
membrane domains has never been definitively proven. The
similar appearance of RSPs in both wild-type and B1-deficient
mice indicates that their morphology is not related to the
presence of a particular B subunit isoform. This agrees with
data from prior studies that revealed RSPs in IC membranes (in
which the B1 subunit is predominant) (15, 22, 56) and also in
the osteoclast ruffled membrane, in which the B2 subunit is
expressed (1). However, the number of RSPs in cells from
B1-deficient mice is reduced by 50% compared with wild-type
mice. It is possible that this reflects a decrease in the associa-
tion of transmembrane V-ATPase subunits into these charac-
teristic particles. Indeed, the RSP reduction correlates well
with the 60% loss of V-ATPase activity measured in OMCD
ICs in the pHi recovery assay.
Our present data partially address the mechanism by which
isoform replacement may occur. The absence of significant
upregulation in B2 expression in the B1/ mouse kidney at
either the mRNA or the protein level suggests that the increase
in apical membrane B2 expression is at least in part due to a
redistribution of B2-containing V-ATPases from the cytoplasm
to the apical membrane domain. That B2-containing holoen-
zymes can recycle between these domains is supported by the
intracellular accumulation of B1-deficient V-ATPases in re-
sponse to colchicine, which blocks this recycling pathway.
These findings are comparable to previously published results
that described the relocation of ATP6V1E1 protein (the ubiq-
uitous V-ATPase 31-kDa E1 subunit isoform) from the cytosol
to the plasma membrane in rat A-ICs in response to chronic
oral acid loading, which occurred in the absence of significant
upregulation in mRNA or protein levels even after 14 days of
treatment (5). Another study also reported no increase in B1
subunit protein levels in mouse kidney cortex or medulla after
up to 7 days of acid loading (26). The results reported here are
also in very good agreement with our recent data showing a
comparable increase in the B2 V-ATPase-associated immuno-
staining in the apical pole of clear cells from the cauda
epididymis of B1-deficient mice (23). Similarly, this increase
cannot be attributed to an upregulation of the B2 isoform at the
mRNA or protein level. One can thus infer that analogous
mechanisms may underline the B2 response to the absence of
functional B1 V-ATPase in proton-secreting renal ICs and
epididymal clear cells.
The pHi recovery data presented here indicate that, unlike in
ICs from the CCD that show no mean pHi recovery in B1/
mice (25), up to 40% of the V-ATPase activity of OMCD
A-ICs is preserved in the absence of the B1 subunit isoform. In
the inner medulla, pHi recovery of ICs was reduced to 28% of
wild-type values, less than in the outer medulla but still potentially
significant enough to contribute to urinary H secretion. In con-
clusion, all the evidence points toward a compensatory mecha-
nism in the medullary CD A-ICs of B1/ mice involving the
alternate 56-kDa B2 isoform, which can play a part in transport-
ing protons across the apical plasma membrane and, thus, bring
an essential contribution to urinary acidification and to the
maintenance of acid-base homeostasis in this animal group
under baseline conditions. The reasons why this mechanism
does not produce similar results in the ICs of the CCD of
B1-deficient mice are currently incompletely understood.
While this disparity may be related, at least in part, to the
differences in the interstitial environment surrounding the cor-
tical and the medullary CD, further investigations will be
required to address this issue.
It should be mentioned that in addition to the V-ATPase
(i.e., B2)-mediated pHi recovery, our data indicate that
sodium-, bicarbonate-, and concanamycin-independent trans-
port processes may also be involved in the normal and B1/
mouse CD. However, the activity of concanamycin-indepen-
dent proton extrusion mechanisms, possibly including the H-
K-ATPase, was similar in normal and B1-deficient mice,
indicating that no detectable compensatory upregulation oc-
curred. The nature of additional non-V-ATPase H extrusion
mechanisms remains to be investigated in future studies.
It has yet to be determined how the B2 subunit can be
incorporated into a functional V-ATPase that is targeted to the
plasma membrane, and why this mechanism is apparently not
sufficient to compensate in humans with dRTA resulting from
B1 subunit mutations. It has been shown that B1 constructs
bearing the single amino acid mutations described in dRTA
patients do not assemble into functional V-ATPase complexes
(67). These mutated B1 subunits impair the plasma membrane
trafficking and insertion of the V-ATPase, possibly by com-
peting with wild-type holoenzymes for components of the
vesicle-targeting machinery. In contrast, the B1-deficient
mouse does not express such an abnormal B1 protein that could
alter trafficking of wild-type V-ATPases. In the complete
absence of B1, it is likely that B2 is free to incorporate into
holoenzymes that are targeted to the plasma membrane based
on as yet unidentified targeting sequences in other subunits,
possibly the transmembrane a4 subunit (46, 53) with which
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both B1 and B2 can associate (59). Further studies, including
the generation of mice expressing B1 subunits that replicate the
human dRTA-inducing mutations will be required to explore
these possibilities.
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